{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:45:18Z","timestamp":1761561918955,"version":"build-2065373602"},"reference-count":8,"publisher":"Elsevier BV","issue":"8","license":[{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2014,11,1]],"date-time":"2014-11-01T00:00:00Z","timestamp":1414800000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cardiovascular Revascularization Medicine"],"published-print":{"date-parts":[[2014,11]]},"DOI":"10.1016\/j.carrev.2014.10.006","type":"journal-article","created":{"date-parts":[[2014,10,25]],"date-time":"2014-10-25T02:01:09Z","timestamp":1414202469000},"page":"402-407","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":3,"title":["Overview of the 2014 Food and Drug Administration Circulatory System Devices Panel meeting regarding the Lutonix\u00ae drug coated balloon"],"prefix":"10.1016","volume":"15","author":[{"given":"Ricardo O.","family":"Esc\u00e1rcega","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ron","family":"Waksman","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.carrev.2014.10.006_bb0005","first-page":"e28","article-title":"Heart disease and stroke statistics\u20142014 update: a report from the American Heart Association","volume":"129","author":"Go","year":"2014","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.10.006_bb0010","doi-asserted-by":"crossref","first-page":"2583","DOI":"10.1161\/CIR.0b013e3182031a3c","volume":"122","author":"Olin","year":"2010","journal-title":"Circulation"},{"key":"10.1016\/j.carrev.2014.10.006_bb0015","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/S1098-3597(02)90012-8","article-title":"Epidemiology and pathophysiology of peripheral arterial disease","volume":"4","author":"Levy","year":"2002","journal-title":"Clin Cornerstone"},{"key":"10.1016\/j.carrev.2014.10.006_bb0020","doi-asserted-by":"crossref","first-page":"e463","DOI":"10.1161\/CIRCULATIONAHA.106.174526","volume":"113","author":"Hirsch","year":"2006","journal-title":"Circulation"},{"issue":"Suppl. 1","key":"10.1016\/j.carrev.2014.10.006_bb0025","doi-asserted-by":"crossref","first-page":"S1","DOI":"10.1016\/j.ejvs.2006.09.024","article-title":"Inter-society consensus for the management of peripheral arterial disease (TASC II)","volume":"33","author":"Norgren","year":"2007","journal-title":"Eur J Vasc Endovasc Surg"},{"key":"10.1016\/j.carrev.2014.10.006_bb0030","doi-asserted-by":"crossref","first-page":"495","DOI":"10.1161\/CIRCINTERVENTIONS.111.962324","article-title":"Paclitaxel-eluting stents show superiority to balloon angioplasty and bare metal stents in femoropopliteal disease: twelve-month Zilver PTX randomized study results","volume":"4","author":"Dake","year":"2011","journal-title":"Circ Cardiovasc Interv"},{"key":"10.1016\/j.carrev.2014.10.006_bb0035","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1016\/j.jcin.2013.05.022","article-title":"The LEVANT I (Lutonix paclitaxel-coated balloon for the prevention of femoropopliteal restenosis) trial for femoropopliteal revascularization: first-in-human randomized trial of low-dose drug-coated balloon versus uncoated balloon angioplasty","volume":"7","author":"Scheinert","year":"2014","journal-title":"J Am Coll Cardiol Intv"},{"key":"10.1016\/j.carrev.2014.10.006_bb0045","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1177\/152660280701400404","article-title":"Duplex sonography versus angiography for assessment of femoropopliteal arterial disease in a \"real-world\" setting","volume":"14","author":"Schlager","year":"2007","journal-title":"J Endovasc Ther"}],"container-title":["Cardiovascular Revascularization Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838914002425?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1553838914002425?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,10,27]],"date-time":"2025-10-27T10:09:55Z","timestamp":1761559795000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1553838914002425"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,11]]},"references-count":8,"journal-issue":{"issue":"8","published-print":{"date-parts":[[2014,11]]}},"alternative-id":["S1553838914002425"],"URL":"https:\/\/doi.org\/10.1016\/j.carrev.2014.10.006","relation":{},"ISSN":["1553-8389"],"issn-type":[{"type":"print","value":"1553-8389"}],"subject":[],"published":{"date-parts":[[2014,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Overview of the 2014 Food and Drug Administration Circulatory System Devices Panel meeting regarding the Lutonix\u00ae drug coated balloon","name":"articletitle","label":"Article Title"},{"value":"Cardiovascular Revascularization Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.carrev.2014.10.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Inc. All rights reserved.","name":"copyright","label":"Copyright"}]}}